As of close of business last night, Healthpeak Properties Inc.’s stock clocked out at $16.24, up 0.37% from its previous closing price of $16.18. In other words, the price has increased by $+0.06 from its previous closing price. On the day, 8349470 shares were traded.
Ratios:
To gain a deeper understanding of PEAK’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 52.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.29. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 1.06.
On January 30, 2024, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $21.
Scotiabank Upgraded its Sector Perform to Sector Outperform on January 12, 2024, whereas the target price for the stock was revised from $20 to $23.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 15 when Lewis Sara Grootwassink bought 4,000 shares for $21.43 per share. The transaction valued at 85,729 led to the insider holds 4,000 shares of the business.
Klaritch Thomas bought 1,517 shares of PEAK for $35,204 on Mar 07. The COO now owns 344,000 shares after completing the transaction at $23.21 per share. On Mar 02, another insider, Brinker Scott M, who serves as the President and CEO of the company, bought 16,300 shares for $23.63 each. As a result, the insider paid 385,169 and bolstered with 206,525 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PEAK now has a Market Capitalization of 8.89B and an Enterprise Value of 15.85B. As of this moment, Healthpeak’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.21, and their Forward P/E ratio for the next fiscal year is 29.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.07 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 7.27 whereas that against EBITDA is 12.53.
Stock Price History:
Over the past 52 weeks, PEAK has reached a high of $24.97, while it has fallen to a 52-week low of $15.24. The 50-Day Moving Average of the stock is 18.91, while the 200-Day Moving Average is calculated to be 19.21.
Shares Statistics:
It appears that PEAK traded 5.90M shares on average per day over the past three months and 7.1M shares per day over the past ten days. A total of 547.16M shares are outstanding, with a floating share count of 545.42M. Insiders hold about 0.32% of the company’s shares, while institutions hold 95.58% stake in the company. Shares short for PEAK as of Jan 31, 2024 were 9.41M with a Short Ratio of 1.59, compared to 8.5M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.72% and a Short% of Float of 2.36%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.20, PEAK has a forward annual dividend rate of 1.20. Against a Trailing Annual Dividend Yield of 7.42%, it implies a Forward Annual Dividend Yield of 7.39%. The stock’s 5-year Average Dividend Yield is 4.83. The current Payout Ratio is 215.83% for PEAK, which recently paid a dividend on Feb 26, 2024 with an ex-dividend date of Feb 13, 2024. Stock splits for the company last occurred on Nov 01, 2016 when the company split stock in a 1098:1000 ratio.
Earnings Estimates
As of right now, 4 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.07 for the current quarter, with a high estimate of $0.1 and a low estimate of $0.02, while EPS last year was $0.22. The consensus estimate for the next quarter is $0.09, with high estimates of $0.13 and low estimates of $0.03.
Analysts are recommending an EPS of between $0.47 and $0.32 for the fiscal current year, implying an average EPS of $0.42. EPS for the following year is $0.56, with 4 analysts recommending between $0.61 and $0.44.
Revenue Estimates
In the current quarter, 5 analysts expect revenue to total $570.66M. It ranges from a high estimate of $627.1M to a low estimate of $543M. As of the current estimate, Healthpeak Properties Inc.’s year-ago sales were $525.68M, an estimated increase of 8.60% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $666.04M, an increase of 24.30% over than the figure of $8.60% in the same quarter last year. There is a high estimate of $739.43M for the next quarter, whereas the lowest estimate is $547M.
A total of 6 analysts have provided revenue estimates for PEAK’s current fiscal year. The highest revenue estimate was $2.85B, while the lowest revenue estimate was $2.2B, resulting in an average revenue estimate of $2.55B. In the same quarter a year ago, actual revenue was $2.18B, up 17.10% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $2.76B in the next fiscal year. The high estimate is $3.15B and the low estimate is $2.25B. The average revenue growth estimate for next year is up 7.90% from the average revenue estimate for this year.
